secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVS HEALTH Corp (CVS)
CIK:        0000064803
Form:       8-K
Filed at:   2023-12-05T23:59:59+00:00
Accession:  0000064803-23-000049
Event type: other
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CVS Health initiates FY24 guidance of at least $8.50 adj EPS, raises dividend 10%
--------------------------------------------------------------------------------

- Introduces CVS CostVantage and CVS Caremark TrueCost for transparent pharmacy reimbursement, launch in 2025.
- Launches CVS Healthspire brand for Health Services segment including Caremark, Oak Street, Signify, MinuteClinic.
- Reiterates FY23 guidance; initiates FY24 projections: revenue >=$366B, adj EPS >=$8.50.
- Board approves quarterly dividend increase to $0.665/share (+10%), payable Feb 1, 2024.
- Aetna achieves 87% of Medicare Advantage members in 4-star+ plans for 2025, up from 21%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/64803/000006480323000049/0000064803-23-000049-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/64803/000006480323000049/cvs-20231205.htm
  HTML page:      https://secwatch.observer/filing/0000064803-23-000049

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer